David Chang
Chief Tech/Sci/R&D Officer at CABALETTA BIO, INC.
Net worth: - $ as of 29/04/2024
Profile
David J.
Chang is currently the Chief Medical Officer at Cabaletta Bio, Inc. Prior to this, he was the Senior Vice President and Head of Immuno-Inflammation and Neurosciences at AstraZeneca Pharmaceuticals LP from 2015 to 2019.
From 2007 to 2015, he was the Vice President and Head of Immuno-Inflammation at GSK Plc.
Dr. Chang received his doctorate degree from New York University School of Medicine, his graduate degree from Emory University, and his undergraduate degree from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CABALETTA BIO, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 29/04/2024 |
David Chang active positions
| Companies | Position | Start |
|---|---|---|
| CABALETTA BIO, INC. | Chief Tech/Sci/R&D Officer | 31/05/2019 |
Former positions of David Chang
| Companies | Position | End |
|---|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 30/04/2019 |
| GSK PLC | Corporate Officer/Principal | 31/05/2015 |
Training of David Chang
| New York University School of Medicine | Doctorate Degree |
| Yale University | Undergraduate Degree |
| Emory University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CABALETTA BIO, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 1 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- David Chang
